Clinical Trial Update: Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD) [Phase 2]

View source ↗

Summary

Open-label extension of a Phase 2 study assessing long-term twice-monthly somavaratan in adults with growth hormone deficiency; study terminated with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somavaratan (somavaratan)

Snippet

Sponsor: Versartis Inc. | Conditions: Adult Growth Hormone Deficiency (AGHD) | Phase 2 | Status: TERMINATED | Results posted: 2023-04-13